Results 121 to 130 of about 21,745 (180)

Immune dysregulation complicated by recurrent in-stent restenosis in patients with multivessel coronary artery disease: a case report. [PDF]

BMC Cardiovasc Disord
Jiang J, Huang Z, Li C, Zhang H, Zhao Z, Yang F, Gai Y, Li F, Gong C, Wu Y.   +9 more
europepmc   +1 more source

The association between glycated hemoglobin levels and in-stent restenosis following percutaneous coronary intervention in coronary artery disease patients. [PDF]

Front Endocrinol (Lausanne)
Lei Y, Jin P, Liu H, Su L, Wu D, Sun C, Wu H, Zhou J, Wang C.   +8 more
europepmc   +1 more source

Reply to Letter to the Editor: "Comments on 'Evaluation of Whole Blood Viscosity to Predict Stent Restenosis'". [PDF]

Anatol J Cardiol
Çalapkulu Y.
europepmc   +1 more source

Outcomes of Drug-Coated Balloon Versus Drug-Eluting Stent for In-Stent Restenosis and De-Novo Lesions: A Meta-Analysis of Randomized Controlled Trials. [PDF]

Health Sci Rep
Moghadam AS, Kazemian S, Shojaei S, Moghadam SS, Dolama RH, Ebrahimi R, Shirmard FO, Pourfaraji SMA, Najafi MS, Hobaby S, Soleimani H, Tajdini M, Tehrani B, Kolte D, Elgendy I, Basavarajaiah S, Latib A, Sattar Y, Chadi Alraies M, Hosseini K.   +19 more
europepmc   +1 more source

Research progress on risk factors for in-stent restenosis following cerebrovascular stent implantation. [PDF]

Front Neurol
Gao H, Bibi H, Tan H, Zhang Y, Yang G, Wang J, Wu T.   +6 more
europepmc   +1 more source

Association of serum total bilirubin with recurrent cardiovascular events in patients with in-stent restenosis: a stratified analysis by inflammatory status. [PDF]

BMC Cardiovasc Disord
Yu M, Jiang Y, Sun Y, Zhang H, Wang TJ, Tian T, Yuan JS, Qian HY, Yang WX.   +8 more
europepmc   +1 more source

Drug-coated balloons in coronary in-stent restenosis: a systematic review and meta-analysis comparing sirolimus and biolimus with paclitaxel platforms. [PDF]

Cardiovasc Interv Ther
Dandamudi M, Faizan MA, Rehman T, Lecchi C, Ghimire M, Inampudi JV, Mojica JC, Chamay S, Giorgi J.   +8 more
europepmc   +1 more source

Intravascular Brachytherapy for In-Stent Restenosis in Patients With Chronic Kidney Disease. [PDF]

J Soc Cardiovasc Angiogr Interv
Sella G, Kharsa C, Kritya M, Olek D, Teh BS, Anwaar MF, Elias J, El Hajj E, Raizner AE, Farach A, Kleiman NS, Shah A.   +11 more
europepmc   +1 more source

Unveiling a Hidden Threat: Wellens Syndrome as a Manifestation of Critical In-Stent Restenosis. [PDF]

Cureus
Sousou JM, Merry TJ, Marsalisi C, Karan A, Reddy P.   +4 more
europepmc   +1 more source

Research advances in the etiology of in-stent restenosis of coronary arteries. [PDF]

Front Cardiovasc Med
Bai H, Zhang B, Sun Y, Wang X, Luan B, Zhang X.   +5 more
europepmc   +1 more source